Top Key Companies for Recombinant Antibody Expression Service Market: GenScript Biotech Corporation, Creative Biolabs, Abnova Corporation, Thermo Fisher Scientific, Bio-Rad Laboratories, Covance Inc., Sino Biological Inc., ProMab Biotechnologies Inc., LakePharma Inc., Genetically Modified Animals Inc., Atlas Antibodies AB, Absolute Antibody Ltd., ProteoGenix, BOC Sciences, Rockland Immunochemicals Inc., Molecular Innovations Inc., Proteintech Group Inc., RayBiotech Inc., BioLegend Inc., Genscript USA Inc., Agilent Technologies, Novus Biologicals LLC, OriGene Technologies Inc., ACROBiosystems, Fitzgerald Industries International.
Global Recombinant Antibody Expression Service Market Size was estimated at USD 803.43 million in 2022 and is projected to reach USD 1994.21 million by 2028, exhibiting a CAGR of 16.36% during the forecast period.
Global Recombinant Antibody Expression Service Market Overview And Scope:
The Global Recombinant Antibody Expression Service Market Report 2023 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Recombinant Antibody Expression Service utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2023 and 2030. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
This Market Research Report provides a comprehensive analysis of the global Recombinant Antibody Expression Service Market and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Recombinant Antibody Expression Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Recombinant Antibody Expression Service market.
Global Recombinant Antibody Expression Service Market Segmentation
By Type, Recombinant Antibody Expression Service market has been segmented into:
Mammalian Cell Expression
Bacterial Expression
Yeast Expression
Insect Cell Expression
Cell-Free Expression
Transgenic Animal Expression
Plant Expression
By Application, Recombinant Antibody Expression Service market has been segmented into:
Research and Development
Diagnostics
Therapeutics
Agriculture and Food
Others
Regional Analysis of Recombinant Antibody Expression Service Market:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape of Recombinant Antibody Expression Service Market:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Recombinant Antibody Expression Service market study focused on including all the primary level, secondary level and tertiary level competitors in the report.The data generated by conducting the primary and secondary research. The report covers detail analysis of driver, constraints and scope for new players entering the Recombinant Antibody Expression Service market.
Top Key Companies Covered in Recombinant Antibody Expression Service market are:
GenScript Biotech Corporation
Creative Biolabs
Abnova Corporation
Thermo Fisher Scientific
Bio-Rad Laboratories
Covance Inc.
Sino Biological Inc.
ProMab Biotechnologies Inc.
LakePharma Inc.
Genetically Modified Animals Inc.
Atlas Antibodies AB
Absolute Antibody Ltd.
ProteoGenix
BOC Sciences
Rockland Immunochemicals Inc.
Molecular Innovations Inc.
Proteintech Group Inc.
RayBiotech Inc.
BioLegend Inc.
Genscript USA Inc.
Agilent Technologies
Novus Biologicals LLC
OriGene Technologies Inc.
ACROBiosystems
Fitzgerald Industries International
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Recombinant Antibody Expression Service Market by Type
5.1 Recombinant Antibody Expression Service Market Overview Snapshot and Growth Engine
5.2 Recombinant Antibody Expression Service Market Overview
5.3 Mammalian Cell Expression
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2016-2030F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Mammalian Cell Expression: Geographic Segmentation
5.4 Bacterial Expression
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2016-2030F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Bacterial Expression: Geographic Segmentation
5.5 Yeast Expression
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2016-2030F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Yeast Expression: Geographic Segmentation
5.6 Insect Cell Expression
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size (2016-2030F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Insect Cell Expression: Geographic Segmentation
5.7 Cell-Free Expression
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size (2016-2030F)
5.7.3 Key Market Trends, Growth Factors and Opportunities
5.7.4 Cell-Free Expression: Geographic Segmentation
5.8 Transgenic Animal Expression
5.8.1 Introduction and Market Overview
5.8.2 Historic and Forecasted Market Size (2016-2030F)
5.8.3 Key Market Trends, Growth Factors and Opportunities
5.8.4 Transgenic Animal Expression: Geographic Segmentation
5.9 Plant Expression
5.9.1 Introduction and Market Overview
5.9.2 Historic and Forecasted Market Size (2016-2030F)
5.9.3 Key Market Trends, Growth Factors and Opportunities
5.9.4 Plant Expression: Geographic Segmentation
Chapter 6: Recombinant Antibody Expression Service Market by Application
6.1 Recombinant Antibody Expression Service Market Overview Snapshot and Growth Engine
6.2 Recombinant Antibody Expression Service Market Overview
6.3 Research and Development
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2016-2030F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Research and Development: Geographic Segmentation
6.4 Diagnostics
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2016-2030F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Diagnostics: Geographic Segmentation
6.5 Therapeutics
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2016-2030F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Therapeutics: Geographic Segmentation
6.6 Agriculture and Food
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size (2016-2030F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Agriculture and Food: Geographic Segmentation
6.7 Others
6.7.1 Introduction and Market Overview
6.7.2 Historic and Forecasted Market Size (2016-2030F)
6.7.3 Key Market Trends, Growth Factors and Opportunities
6.7.4 Others: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Recombinant Antibody Expression Service Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Recombinant Antibody Expression Service Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Recombinant Antibody Expression Service Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 GENSCRIPT BIOTECH CORPORATION
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 CREATIVE BIOLABS
7.4 ABNOVA CORPORATION
7.5 THERMO FISHER SCIENTIFIC
7.6 BIO-RAD LABORATORIES
7.7 COVANCE INC.
7.8 SINO BIOLOGICAL INC.
7.9 PROMAB BIOTECHNOLOGIES INC.
7.10 LAKEPHARMA INC.
7.11 GENETICALLY MODIFIED ANIMALS INC.
7.12 ATLAS ANTIBODIES AB
7.13 ABSOLUTE ANTIBODY LTD.
7.14 PROTEOGENIX
7.15 BOC SCIENCES
7.16 ROCKLAND IMMUNOCHEMICALS INC.
7.17 MOLECULAR INNOVATIONS INC.
7.18 PROTEINTECH GROUP INC.
7.19 RAYBIOTECH INC.
7.20 BIOLEGEND INC.
7.21 GENSCRIPT USA INC.
7.22 AGILENT TECHNOLOGIES
7.23 NOVUS BIOLOGICALS LLC
7.24 ORIGENE TECHNOLOGIES INC.
7.25 ACROBIOSYSTEMS
7.26 FITZGERALD INDUSTRIES INTERNATIONAL
Chapter 8: Global Recombinant Antibody Expression Service Market Analysis, Insights and Forecast, 2016-2030
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Mammalian Cell Expression
8.2.2 Bacterial Expression
8.2.3 Yeast Expression
8.2.4 Insect Cell Expression
8.2.5 Cell-Free Expression
8.2.6 Transgenic Animal Expression
8.2.7 Plant Expression
8.3 Historic and Forecasted Market Size By Application
8.3.1 Research and Development
8.3.2 Diagnostics
8.3.3 Therapeutics
8.3.4 Agriculture and Food
8.3.5 Others
Chapter 9: North America Recombinant Antibody Expression Service Market Analysis, Insights and Forecast, 2016-2030
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Mammalian Cell Expression
9.4.2 Bacterial Expression
9.4.3 Yeast Expression
9.4.4 Insect Cell Expression
9.4.5 Cell-Free Expression
9.4.6 Transgenic Animal Expression
9.4.7 Plant Expression
9.5 Historic and Forecasted Market Size By Application
9.5.1 Research and Development
9.5.2 Diagnostics
9.5.3 Therapeutics
9.5.4 Agriculture and Food
9.5.5 Others
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Recombinant Antibody Expression Service Market Analysis, Insights and Forecast, 2016-2030
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Mammalian Cell Expression
10.4.2 Bacterial Expression
10.4.3 Yeast Expression
10.4.4 Insect Cell Expression
10.4.5 Cell-Free Expression
10.4.6 Transgenic Animal Expression
10.4.7 Plant Expression
10.5 Historic and Forecasted Market Size By Application
10.5.1 Research and Development
10.5.2 Diagnostics
10.5.3 Therapeutics
10.5.4 Agriculture and Food
10.5.5 Others
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Recombinant Antibody Expression Service Market Analysis, Insights and Forecast, 2016-2030
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Mammalian Cell Expression
11.4.2 Bacterial Expression
11.4.3 Yeast Expression
11.4.4 Insect Cell Expression
11.4.5 Cell-Free Expression
11.4.6 Transgenic Animal Expression
11.4.7 Plant Expression
11.5 Historic and Forecasted Market Size By Application
11.5.1 Research and Development
11.5.2 Diagnostics
11.5.3 Therapeutics
11.5.4 Agriculture and Food
11.5.5 Others
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Recombinant Antibody Expression Service Market Analysis, Insights and Forecast, 2016-2030
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Mammalian Cell Expression
12.4.2 Bacterial Expression
12.4.3 Yeast Expression
12.4.4 Insect Cell Expression
12.4.5 Cell-Free Expression
12.4.6 Transgenic Animal Expression
12.4.7 Plant Expression
12.5 Historic and Forecasted Market Size By Application
12.5.1 Research and Development
12.5.2 Diagnostics
12.5.3 Therapeutics
12.5.4 Agriculture and Food
12.5.5 Others
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Recombinant Antibody Expression Service Market Analysis, Insights and Forecast, 2016-2030
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Mammalian Cell Expression
13.4.2 Bacterial Expression
13.4.3 Yeast Expression
13.4.4 Insect Cell Expression
13.4.5 Cell-Free Expression
13.4.6 Transgenic Animal Expression
13.4.7 Plant Expression
13.5 Historic and Forecasted Market Size By Application
13.5.1 Research and Development
13.5.2 Diagnostics
13.5.3 Therapeutics
13.5.4 Agriculture and Food
13.5.5 Others
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Recombinant Antibody Expression Service Market Analysis, Insights and Forecast, 2016-2030
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Mammalian Cell Expression
14.4.2 Bacterial Expression
14.4.3 Yeast Expression
14.4.4 Insect Cell Expression
14.4.5 Cell-Free Expression
14.4.6 Transgenic Animal Expression
14.4.7 Plant Expression
14.5 Historic and Forecasted Market Size By Application
14.5.1 Research and Development
14.5.2 Diagnostics
14.5.3 Therapeutics
14.5.4 Agriculture and Food
14.5.5 Others
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Recombinant Antibody Expression Service Scope:
Report Data
|
Recombinant Antibody Expression Service Market
|
Recombinant Antibody Expression Service Market Size in 2022
|
USD 803.43 million
|
Recombinant Antibody Expression Service CAGR 2023 - 2030
|
16.36%
|
Recombinant Antibody Expression Service Base Year
|
2022
|
Recombinant Antibody Expression Service Forecast Data
|
2023 - 2030
|
Segments Covered
|
By Type, By Application, And by Regions
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
Key Companies Profiled
|
GenScript Biotech Corporation, Creative Biolabs, Abnova Corporation, Thermo Fisher Scientific, Bio-Rad Laboratories, Covance Inc., Sino Biological Inc., ProMab Biotechnologies Inc., LakePharma Inc., Genetically Modified Animals Inc., Atlas Antibodies AB, Absolute Antibody Ltd., ProteoGenix, BOC Sciences, Rockland Immunochemicals Inc., Molecular Innovations Inc., Proteintech Group Inc., RayBiotech Inc., BioLegend Inc., Genscript USA Inc., Agilent Technologies, Novus Biologicals LLC, OriGene Technologies Inc., ACROBiosystems, Fitzgerald Industries International.
|
Key Segments
|
By Type
Mammalian Cell Expression Bacterial Expression Yeast Expression Insect Cell Expression Cell-Free Expression Transgenic Animal Expression Plant Expression
By Applications
Research and Development Diagnostics Therapeutics Agriculture and Food Others
|
Research Methodology